Conagen’s Novel Non-GMO Human Milk Oligosaccharide Paves The Way For Advancing Nutrition In Next Generation Infant Formulas
Bedford, Mass., Aug 21 (Bernama-GLOBE NEWSWIRE) —Conagen, a rapidly-growing Boston-based biotechnology firm, has established a novel and proprietary process for the scalable production of a non-GMO human milk oligosaccharide (HMO), an important nutritional compound only found in human milk. This micronutrition breakthrough will enable the creation of high-quality and cost-effective…

